/*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} Problem 138 . Antiretroviral agents in the f... [FREE SOLUTION] | 91影视

91影视

Log out

Learning Materials

Features

Discover

Chapter 6: Problem 138

. Antiretroviral agents in the fusion class, such as infuvirtide (Fuzeon), inhibit HIV viral replication by: 1\. fusing the intracellular contents rendering them harmless. 2\. inhibiting the fusion of HIV positive cells to each other permitting macrophages to move in to phagocytose the positive cell. 3\. fusing the HIV positive cell with a killer T cell. 4\. inhibiting the HIV virus from fusing with a normal cell.

Short Answer

Expert verified
Fusion inhibitors prevent HIV from merging with normal cells, so option 4 is correct.

Step by step solution

01

Understanding the Mechanism of Fusion Inhibitors

Fusion inhibitors, like enfuvirtide (Fuzeon), are a class of antiretroviral agents designed to prevent HIV from entering human cells. They achieve this by blocking the viral and cellular membranes from fusing together, which is an essential step for the virus to inject its genetic material into the cell.
02

Analyzing the Choices

Let's examine each option: 1. This option suggests intracellular fusion, which is not the mechanism of fusion inhibitors. 2. This option discusses inhibiting fusion of positive cells and role of macrophages, which is unrelated to fusion inhibitors' primary function. 3. This option speaks of fusing an HIV-infected cell with a killer T cell, which is not correct. 4. This choice directly mentions inhibiting the fusion of the virus with a normal cell, matching the function of fusion inhibitors.
03

Selecting the Correct Answer

Fusion inhibitors specifically prevent the virus from merging with host cells, stopping HIV's ability to replicate. Based on the analysis, option 4 is the correct mechanism described by fusion inhibitors.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91影视!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

HIV Replication
HIV replication is a process that allows the HIV virus to multiply and spread in the body. When HIV enters the body, it targets the immune system's CD4 cells, which are a type of white blood cell crucial for fighting infections. Here's a simplified view of how it replicates:
  • First, the HIV virus binds to a CD4 cell.
  • It then fuses with the cell membrane and injects its RNA into the host cell.
  • The viral RNA is converted into DNA by an enzyme called reverse transcriptase.
  • This viral DNA gets integrated into the host cell's DNA, allowing the virus to take over the cell's machinery to produce more viral particles.
  • Newly created viruses leave the host cell to infect other CD4 cells.
By continuously replicating in this manner, HIV weakens the immune system, leaving the body vulnerable to opportunistic infections and diseases. Understanding this process is vital for developing treatments that can effectively block one or more steps in the HIV life cycle.
Fusion Inhibitors
Fusion inhibitors are a specialized class of antiretroviral agents that play a critical role in preventing HIV from infecting human cells. Their main action is to stop the virus from merging with the host cell membrane:
  • The virus normally attaches to a host cell via proteins on its surface.
  • Fusion inhibitors, like enfuvirtide (Fuzeon), interfere with these proteins, preventing the viral envelope from fusing with the cell membrane.
  • This blockade is crucial because, without fusion, the virus cannot inject its genetic material into the host cell, halting its replication cycle.
By ensuring that the virus stays outside the cell, fusion inhibitors prevent HIV from proliferating. Though fusion inhibitors are not a standalone solution for treating HIV, they are often part of a combination therapy that tackles various stages of the viral life cycle.
HIV Treatment Mechanism
The mechanism behind HIV treatment involves a variety of drugs working in tandem to halt the virus's replication process. Given the complexity of HIV, treatment typically involves a combination of different antiretroviral medications:
  • Reverse Transcriptase Inhibitors: These drugs block the enzyme that converts viral RNA into DNA, preventing the integration of the virus into the host's genetic material.
  • Protease Inhibitors: They inhibit another viral enzyme needed for cutting the virus's immature proteins into their final, functional form.
  • Fusion Inhibitors: As discussed, they stop the virus from entering the host cells altogether.
  • Integrase Inhibitors: These prevent the viral DNA from being inserted into the host cell's DNA.
By utilizing these different mechanisms, antiretroviral therapy aims to reduce the viral load in the body, maintain immune function, and minimize the chances of the virus developing drug resistance. Each drug class targets a different step in HIV replication, providing a multi-faceted approach to controlling the infection.

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

Your patient has cholestatic liver disease from prolonged total parenteral nutrition administration and hepatic herpes (HSV) infection. What process of pharmacokinetics may be affected by his disease? 1\. absorption 2\. distribution 3\. metabolism 4\. elimination

. Which class of drugs has the side effect of slowing gastric emptying and blocking intestinal hypermotility and bladder spasms? 1\. cholinergic receptor agonists 2\. adrenergic receptor agonists 3\. cholinergic receptor antagonists 4\. adrenergic receptor antagonists

A patient has been receiving chemotherapy to shrink a thoracic tumor. Chemotherapeutic side effects have made eating difficult. The date for surgical removal of his tumor is approaching. Why would the physician initiate total parenteral nutrition (TPN) at this point? 1\. He wouldn鈥檛. TPN will cause the tumor to grow. 2\. To treat malnutrition and optimize the surgical outcome. 3\. Because the patient is depressed about his cancer and the chemotherapy side effects. 4\. It is the standard of all surgeons to initiate TPN prior to surgery.

The nurse notices a patient鈥檚 IV fluids are slightly cloudy. The nurse: 1\. will permit the fluids to continue to infuse. 2\. knows this is normal with some parenteral fluids. 3\. will check the expiration date on the fluids. 4\. stops the infusion and hangs a bag of clear solution.

. A post-operative patient is receiving morphine sulfate via the intravenous route. Analgesia is effective. The physician changes the medication to the oral route at the same dosage. Subsequently, the patient states that he is getting very little pain relief. The nurse realizes that: 1\. the patient is becoming dependent on the drug. 2\. first pass effect is eliminating much of the oral dose. 3\. the patient is exhibiting drug-seeking behavior. 4\. tolerance to the medication has developed.
See all solutions

Recommended explanations on Biology Textbooks

Organ Systems

Read Explanation

Responding to Change

Read Explanation

Reproduction

Read Explanation

Bioenergetics

Read Explanation

Astrobiological Science

Read Explanation

Cell Cycle

Read Explanation
View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.